Benefits versus risks associated with consumption of fish and other seafood

Reviews on Environmental Health

Volumn 25, Issue 3, 2010, Pages 161-191

  Bushkin Bedient, Sheila ^a   Carpenter, David O ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cardiovascular; Immune system; Methylmercury; Nervous system; Omega 3; Omega 6; PCBs; POPs; PUFA

Indexed keywords

VERTEBRATA;

EID: 78149454072     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVEH.2010.25.3.161     Document Type: Review

References (215)

1. Surette ME. The science behind dietary omega-3 fatty acids. CMAJ. 2008;178(2):177-80.
2. Neuringer M, Connor WE. N-3 fatty acids in the brain and retina: evidence for their essentiality. Nutr Rev. 1986;44(9):285-94.
3. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, Ellis L, et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci. 2007;27(16):4385-95. (Pubitemid 46640724)
4. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2 (8666):757-61.
5. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, et al. Association of n3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361(9356):477-85. (Pubitemid 36173713)
6. Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 2000;71(1 Suppl):339S-42S.
7. Grandjean P, Weihe P, White RF, Debes F. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res. 1998;77(2): 165-72.
8. Carpenter DO. Environmental contaminants and learning and memory. International Congress Series 2006;1287:185-9.
9. Guallar E, Sanz-Gallardo MI, vant Veer P, Bode P, Aro A, Gómez-Aracena J, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347(22): 1747-54.
10. Ha MH, Lee DH, Jacobs DR. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 2007; 115(8): 1204-9.
11. Cogliano VJ. Assessing the cancer risk from environmental PCBs. Environ Health Perspect 1998;106(6):317-23.
12. Walker NJ, Crockett PW, Nyska A, Brix AE, Jokinen MP, Sells DM, et al. Dose-additive carcinogenicity of a defined mixture of 'dioxinlike compounds' Environ Health Perspect 2005; 113(1): 43-8.
13. Terry PD, Rohan TE, Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr. 2003;77(3):532-43.
14. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science. 1972; 175(23):720-31.
15. Los DA, Murata N. Membrane fluidity and its roles in the perception of environmental signals. Biochim Biophys Acta. 2004;1666(1-2):142-57. (Pubitemid 39425203)
16. Vigh L, Escriba PV, Sonnleitner A, Sonnleitner M, Piotto S, Baresca B, et al.. The significance of lipid composition for membrane activity: New concepts and ways of assessing function. Prog Lipid Res 2005; 44:303-344.
17. Connor WE. Alpha-linolenic acid in health and disease. Am J Clin Nutr. 1999;69(5):827-8.
18. Hamilton MC, Hites RA, Schwager SJ, Foran JA, Knuth BA, Carpenter DO. Lipid composition and contaminants in farmed and wild salmon. Environ Sci Technol. 2005;39(22):8622-9.
19. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):329-49.
20. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr. 1994;60(2): 189-94.
21. Moriguchi T, Lim SY, Greiner R, Lefkowitz W, Loewke J, Hoshiba J, et al. Effects of an n-3deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats. J Lipid Res. 2004 ;45(8): 1437-45. (Pubitemid 39006971)
22. Serhan CN, Gotlinger K, Hong S, Arita M. Resolvins, docosatrienes, and neuroprotectins, novel n-3-derived mediators, and their aspirintriggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Médiat. 2004;73(3-4): 155-72.
23. Arita M, Yoshida M, Hong S, Tjonahen E, Gl'ckman JN, Petasis NA, et al. Resolvin El, an endogenous lipid mediator derived from n-3 eicosapentaenoic acid, protects against 2,4,6trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA. 2005;102(21):7671-6.
24. Bazan NG. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling. Cell Mo Neurobiol. 2006;26:901-13.
25. Bazan NG. Omega-3 fatty acids, pro-inflam-matory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care. 2007;10:136-41.
26. Gleissman H, Johnsen JI, Kogner P. Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? Exp Cell Res. 2010;316(8): 1365-73.
27. Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA, Millward DJ. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res. 2005;46(2):269-80.
28. Harper CR, Jacobson TA. The fats of life. The role of n-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med. 2001; 161:2185-92.
29. Serhan CN. Lipoxins and aspirin-triggered 15-epilipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids. 2005; 73(3-4): 141-62.
30. Kris-Etherton P, Fleming J, Harris WS. The debate about n-6 polyunsaturated fatty acid recommendations for cardiovascular health. J Am Diet Assoc. 2010;110:201-4.
31. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997;127(8):1435-44. (Pubitemid 27323451)
32. Kapoor R, Huang YS. Gamma linolenic acid: an antiinflammatory n-6 fatty acid. Curr Pharm Biotechnol. 2006;7(6):531-4.
33. McNamara RK, Jandacek R, Rider T, Tso P, Hahn CG, Richtand NM, et al. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophr Res. 2007; 91(1-3):37-50. (Pubitemid 46320885)
34. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365-79.
35. Stanley JC, Elsom RL, Calder PC, Griffin BA, Harris WS, Jebb SA, et al. UK Food Standards Agency Workshop Report: the effects of the dietary n-6:n-3 fatty acid ratio on cardiovascular health. Br J Nutr.2007;98(6):1305-10.
36. Fritsche KL. Too much linoleic acid promotes inflammation-doesn't it? Prostaglandins Leukot Essent Fatty Acids. 2008;79(3-5): 173-5.
37. Sinclair HM (1956). Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet. 1956; 270:381-3.
38. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr. 1980;33( 12):2657-61.
39. Simopoulos AP. The importance of the omega6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233(6):674-88.
40. Garcí-Closas R, Serra-Majem L, Segura R. Fish consumption, omega-3 fatty acids and the Mediterranean diet. Eur J Clin Nutr. 1993;47 Suppl 1:S85-90.
41. König A, Bouzan C, Cohen JT, Connor WE, KrisEtherton PM, Gray GM, et al. A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med 2005;29(4): 335-46.
42. Psota TL, Gebauer SK, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol. 2006;98(4A):3i-18i.
43. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279 (1):23-8.
44. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336(15): 1046-53.
45. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004;109(22):2705-11.
46. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-8. (Pubitemid 34984601)
47. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003 ; 107(21 ):2646-52.
48. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105(16): 1897-903.
49. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567): 1090-8.
50. Burr ML, Dunstan FD, George CH. Is fish oil good or bad for heart disease? Two trials with apparently conflicting results. J Membr Biol. 2005;206(2):155-63.
51. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112(4):298-304. (Pubitemid 34219443)
52. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15): 1885-99. (Pubitemid 44596197)
53. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, et al. N-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84(1):5-17.
54. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332(7544):752-60.
55. Jenkins DJ, Josse AR, Beyene J, Dorian P, Burr ML, LaBelle R, et al. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ. 2008;178(2):157-64.
56. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, et al. Fish oil supplementation and risk of ventricular tachy-cardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293(23):2884-91.
57. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005; 112(18):2762-8. (Pubitemid 41641669)
58. Brouwer IA, Zock PL, Camm AJ, Böcker D, Hauer RN, Wever EF, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006;295(22):2613-9.
59. Frost L, Vestergaard P. N-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr.2005;81(1):50-4. (Pubitemid 43073375)
60. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002; 106(21): 2747-57.
61. Leaf A, Xiao YF. The modulation of ionic currents in excitable tissues by n-3 poly-unsaturated fatty acids. J Memb Biol. 2001 ;184: 263-71.
62. Bjerregaard P, Young TK, Hegele RA. Low incidence of cardiovascular disease among the Inuit-what is the evidence? Atherosclerosis. 2003 ;166(2):351-7.
63. Kromhout D, Bloemberg BP, Feskens EJ, Hertog MG, Menotti A, Blackburn H. Alcohol, fish, fibre and antioxidant vitamins intake do not explain population differences in coronary heart disease mortality. Int J Epidemiol. 1996;25(4):753-9. (Pubitemid 26290057)
64. Schmidt EB, Rasmussen LH, Rasmussen JG, Joensen AM, Madsen MB, Christensen JH. Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: a minireview with focus on clinical trial data. Prostaglandins Leukot Essent Fatty Acids. 2006;75(3):191-5.
65. Ebbesson SO, Roman MJ, Devereux RB, Kaufman D, Fabsitz RR, Maccluer JW, et al. Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: the Genetics of Ccronary Artery Disease in Alaska Natives study. Atherosclerosis. 2008;199(2):346-53.
66. Kandasamy N, Joseph F, Goenka N. The role of omega-3 fatty acids in cardiovascular disease, hypertriglyceridaemia and diabetes mellitus. Br J Diabetes Vase Dis 2008;8:121-6.
67. Goodnight SH Jr, Harris WS, Connor WE, Illingworth DR. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis. 1982;2(2):87-113. (Pubitemid 12084411)
68. Levinson PD, Iosiphidis AH, Saritelli AL, Herbert PN, Steiner M. Effects of n-3 fatty acids in essential hypertension. Am J Hypertens. 1990;3 (10):754-60.
69. Demaison L, Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart diseaserelated mortality: a possible mechanism of action. Cell Mol Life Sci. 2002;59(3):463-77. (Pubitemid 34267387)
70. Berstad P, Seljeflot I, Veierad MB, Hjerkinn EM, Amesen H, Pedersen JI. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum nonesterified fatty acids and soluble vascular cell adhesion molecule-1. Clin Sci (Lond). 2003;105 (1): 13-20.
71. Harris WS. Omega-3 long-chain PUFA and triglyceride lowering: minimum effective intakes. Eur Heart J. 2001;Suppl 3:D59-D61.
72. Wilt TJ, Lofgren RP, Nichol KL, Schorer AE, Crespin L, Downes D, Eckfeldt J. Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled cross-over study. Ann Intern Med. 1989;111(11):900-5.
73. Lombardo YB, Chicco AG. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem. 2006;17(1):1-13.
74. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006;113 (17):2062-70.
75. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, doubleblind, placebo-controlled trial. Ann Intern Med. 1999;130(7):554-62.
76. Catalan J, Slotnick B, Moriguchi T, Murthy M, Greiner RS, Salme N. Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosci. 2002; 116(6): 1022-31.
77. Uauy R, Dangour AD. Nutrition in brain development and aging: role of essential fatty acids. NunRev 2006;64(5 Pt 2):S24-33; discussion S72-91.
78. Wurtman RJ. Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism. 2008; 57Suppl 2:S6-10.
79. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA. 1993 ;90(3): 1073-7.
80. van Eijsden M, Hornstra G, van der Wal MF, Vrijkotte TG, Bonsel GJ. Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. Am J Clin Nutr. 2008;87(4):887-95.
81. Carlson SE, Werkman SH, Peeples JM, Wilsom WM. Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur J Clin Nutr. 1994;48 Suppl 2:S27-30.
82. Cao D, Xue R, Xu J, Liu Z. Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J Nutr Biochem. 2005;16(9):538-46.
83. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):259-69.
84. Nishikawa M, Kimura S, Akaike N. Facilitatory effect of docosahexaenoic acid on N-methyl-Daspartate response in pyramidal neurones of rat cerebral cortex. J Physiol. 1994;475(1):83-93.
85. Grintal B, Champeil-Potokar G, Lavialle M, Vancassel S, Breton S, Denis I. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid. Neurochem Int 2009;54 (8):535-43.
86. 2+ (ARC) channels. J Biol Chem 2003;278(12): 10174-81.
87. Moriguchi T, Greiner RS, Salem N Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem. 2000;75(6):2563-73.
88. Moriguchi T, Salem N Jr. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem. 2003;87(2):297-309.
89. Gamoh S, Hashimoto M, Hossain S, Masumura S. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 2001;28 (4):266-70.
90. Carnielli VP, Wattimena DJ, Luijendijk IH, Boerlage A, Degenhart HJ, Sauer PJ. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr Res. 1996;40(1): 169-74.
91. Lucas A, Staffer M, Morley R, Abbott R, Stephenson T, MacFadyen U, et al. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomised trial. Lancet. 1999;354(9194): 1948-54.
92. Ghys A, Bakker E, Hornstra G, van den Hout M. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum Dev. 2002;69(1-2):83-90.
93. Birch EE, Castaneda YS, Wheaton DH, Birch DG, Uauy RD, Hoffman DR. Visual maturation of term infants fed long-chain polyunsaturated fatty acidsupplemented or control formula for 12 mo. Am J Clin Nutr. 2005;81(4):871-9.
94. Ryan AS, Astwood JD, Gautier S, Kuratko CN, Nelson EB, Salem N Jr. Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: A review of human studies. Prostaglandins Leukot Essent Fatty Acids. 2010;82(4-6):305-14
95. SanGiovanni JP, Berkey CS, Dwyer JT, Colditz GA. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review. Early Hum Dev. 2000;57(3): 165-88.
96. Hibbeln JR, David JM, Steer C, Emmett P, Rogers I, Williams C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet. 2007;369(9561):578-85.
97. Birch EE, Garfield S, Castañeda Y, HughbanksWheaton D, Uauy R, Hoffman D. Visual acuity and cognitive outcomes at 4 years of age in a doubleblind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev. 2007;83(5):279-84.
98. Angelsen NK, Vik T, Jacobsen G, Bakketeig LS. Breast feeding and cognitive development at age 1 and 5 years. Arch Dis Child. 2001;85(3): 183-8. (Pubitemid 32822374)
99. Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry. 2006; 18(2): 155-72.
100. Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Chaudhary A, Bhave S and Pandit A. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids. 2006;74(1): 17-21. (Pubitemid 41773064)
101. Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav. 1996;59(4-5):915-20.
102. Morris MC, Evans DA, Tangney CC, Baienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol. 2005;62(12):1849-53.
103. Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Torres F, Rizzo C, Capurso A, Panza F. Dietary intake of unsaturated fatty acids and age-related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging. 2006;27(11): 1694-704.
104. Noaghiul S, Hibbeln JR. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry. 2003; 160 (12):2222-7.
105. De Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression. Life Sci. 2003;73(25):3181-7.
106. Iribarren C, Markovitz JH, Jacobs DR, Schreiner PJ, Daviglus M, Hibbeln JR. Dietary intake of omega-3, omega-6 fatty acids and fish: Relationship with hostility in young adults-the CARDIA study. Eur J Clin Nutr. 2004;58(1):24-31.
107. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and omega-3 fatty acids and risk of incident Alzheimer Disease. Arch Neurol. 2003;60(7): 940-6.
108. Hibbeln JR, Ferguson TA, Blasbalg TL. Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: opportunities for intervention. Int Rev Psychiatry 2006;18(2):107-18.
109. Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D. Effects of omega-3 longchain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr. 2006;84(6):1308-16.
110. Miura K, Stamler J, Nakagawa H, Elliott P, Ueshima H, Chan Q, et al. Relationship of dietary linoleic acid to blood pressure. The International Study of Macro-Micronutrients and Blood Pressure Study. Hypertension 2008;52(2):408-14.
111. Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol. 1995;48(11):1379-90.
112. Calder PC. N-3 fatty acids, inflammation, and immunity-relevance to postsurgical and critically ill patients. Lipids. 2004;39(12):1147-61.
113. Reisman J, Schachter HM, Dales RE, Tran K, Kourad K, Barnes D, et al. Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement Altern Med. 2006;6:26.
114. Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006;84(6): 1290-8.
115. Shah M, Adams-Huet B, Brinkley L, Grundy SM, Garg A. Lipid, glycemic, and insulin responses to meals rich in saturated, cis-monounsaturated, and polyunsaturated (n-3 and n-6) fatty acids in subjects with type 2 diabetes. Diabetes Care. 2007;30(12): 2993-8.
116. Institute of Medicine (IOM). Seafood choices: balancing benefits and risks. The National Academies Press; 2006. Available at: http://www.iom.edu/ Reports/2006/Seafood-Choices-Balancing- Benefits-and-Risks.aspx
117. Mori TA, Beilin LJ. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep. 2004;6(6): 461-7.
118. Leaf A, Xiao YF, Kang JX and Billman GE. Membrane effects of the n-3 fish oil fatty acids, whicn prevent fatal ventricular arrhythmias. J Membr Biol. 2005;206(2): 129-39.
119. Leaf A, Kang JX, Xiao YF. Fish oil fatty acids as cardiovascular drugs. Curr Vase Pharmacol. 2008; 6(1):1-12.
120. Kang JX, Leaf A. Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoyl-carnitine in neonatal rat cardiac myocytes. Eur J Pharmacol. 1996;297(1-2):97-106. (Pubitemid 26062149)
121. + channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA. 1995;92:11000-4.
122. Kang JX, Li Y, Leaf A. Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n-3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes. Proc Natl Acad Sci USA. 1997 Mar 18;94(6):2724-8.
123. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA. 1997;94(8):4182-7.
124. Prasad A, Åhs M, Goncharov A, Carpenter DO. Omega-3 and omega-6 fatty acids kill thymocytes and increase membrane fluidity. Open Cell Dev Biol J 2010:2:1-7.
125. Stulnig TM. Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol. 2003;132(4):310-21.
126. Galli C, Calder PC. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab. 2009;55(1-3): 123-39.
127. Shaikh SR, Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr. 2006;84(6): 1277-89.
128. Zeyda M, Szekeres AB, Säemann MD, Geyeregger R, Stockinger H, Zlabinger GJ, et al. Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogenactivated protein kinase and nuclear factor activation. J Immunol. 2003; 170(12):6033-9.
129. Geyeregger R, Zeyda M, Zlabinger GJ, Waldhäusl W, Stulnig TM. Polyunsaturated fatty acids interfere with formation of the immunological synapse. J Leukoc Biol. 2005;77(5):680-8.
130. Otton R, Curi R. Toxicity of a mixture of fatty acids on human blood lymphocytes and leukaemia cell lines. Toxicol In Vitro. 2005;19(6):749-55.
131. Finstad HS, Dyrendal H, Myhrstad MC, Heimli H, Drevon CA. Uptake and activation of eicosapentaenoic acid are related to accumulation of triacylglycerol in Ramos cells dying from apoptosis. J Lipid Res. 2000;41(4):554-63.
132. Siddiqui RA, Jenski LJ, Harvey KA, Wiesehan JD, Stillwell W, Zaloga GP. Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem J. 2003;371(Pt 2): 621-9.
133. 2+)(i) levels in acutely isolated mouse thymocytes. Cell Biochem Funct. 2009; 27(3): 155-61.
134. Kim HJ, Vosseler CA, Weber PC, Erl W. Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells. J Cell Physiol. 2005;204(3):881-8. (Pubitemid 41099273)
135. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med 2003;349(18):1731-7. (Pubitemid 37315011)
136. Mahaffey KR. Mercury exposure: medical and public health issues. Trans Am Clin Climatol Assoc. 2005;116:127-53; discussion 153-4.
137. Shim SM, Lasrado JA, Dorworth LE, Santerre CR. Mercury and fatty acids in canned tuna, salmon, and mackerel. J Food Prot. 2005;68(3): 633-5.
138. Madsen ER, DeWeese AD, Kmiecik NE, Foran JA, Chiriboga ED. Methods to develop consumption advice for methylmercury-contaminated walleye harvested by Ojibwe tribes in the 1837 and 1842 ceded territories of Michigan, Minnesota, and Wisconsin, USA. Integr Environ Assess Manag 2008;4(1): 118-24.
139. Simonin HA, Loukmas JJ, Skinner LC, Roy KM. Strategic monitoring of mercury in New York State fish. New York State. Energy Research and Development Authority; 2008.
140. Watanabe C, Satoh H. Evolution of our understanding of methylmercury as a health threat. Environ Health Perspect 1996; 104 Suppl 2:367-79.
141. Gilbertson M. Index of congenital Minamata disease (CMD) in Canadian areas of concern in the Great Lakes: an eco-social epidemiological approach. J Environ Sci Heal C. 2010;27:246-275.
142. Debes F, Budtz-Jergensen E, Weihe P, White RF, Grandjean P. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol. 2006;28(5):536-47.
143. Davidson PW, Myers GJ, Cox C, Wilding GE, Shamlaye CF, Huang LS, et al. Methylmercury and neurodevelopment: longitudinal analysis of the Seychelles child development cohort. Neurotoxics Teratol. 2006;28(5):529-35.
144. Kjellström T, Kennedy P, Wallis S, Stewart A, Friberg L, Lind B, et al. Physical and mental development of children with prenatal exposure to mercury from fish: stage 2. Interviews and psychological tests at age 6. Natl Swed Environ Board Rep 3642. 1989; Solna, Sweden.
145. Lebel J, Mergler D, Lucotte M, Amorim M, Dolbec J, Miranda D, et al. Evidence of early nervous system dysfunction in Amazonian populations exposed to low-levels of methyl-mercury. Neurotoxicology. 1996;17(1):157-67.
146. National Academy of Sciences (NAS). Toxicological effects of methylmercury. Washington, D.C. National Academy of Sciences Press; 2000.
147. Mahaffey KR, Clickner RP, Bodurow CC. Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000. Environ Health Perspect 2004; 112(5):562-70.
148. Stern AH, Smith AE. An assessment of the cord bIood:maternal blood methylmercury ratio: implications for risk assessment. Environ Health Perspect 2003;111(12): 1465-70.
149. Trasande L, Landrigan PJ, Schechter C. Public health and economic consequences of methyl mercury toxicity to the developing brain. Environ Health Perspect 2005; 113(5):590-6.
150. Al-Shahristani H, Shahab KM. Variation of biological half-life of methylmercury in man. Arch Environ Health. 1974;28(6):342-4.
151. Yokoo EM, Valente JG, Grattan L, Schmidt SL, Piatt I, Silbergeld EK. Low level methylmercury exposure affects neuropsychological function in adults. Environ Health. 2003;2(1):8.
152. Hightower JM, Moore D. Mercury levels in highend consumers of fish. Environ Health Perspect 2003;111(4):604-8.
153. Salonen JT, Seppänen K, Nyyssönen K, Korpela H, Kauhanen J, Kantola M, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91(3):645-55.
154. Wolff MS, Fischbein A, Selikoff IJ. Changes in PCB serum concentrations among capacitor manufacturing workers. Environ Res. 1992;59(1): 202-16.
155. Huang X, Hites RA, Foran JA, Hamilton C, Knuth BA, Schwager SJ, et al. Consumption advisories for salmon based on risk of cancer and noncancer health effects. Environ Res. 2006;101(2):263-74.
156. Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med. 1996;335(11): 783-9.
157. Stewart PW, Reihman J, Lonky EI, Darvill TJ, Pagano J. Cognitive development in preschool children prenatally exposed to PCBs and MeHg. Neurotoxicol Teratol. 2003 ;25(1):11-22. (Pubitemid 36287499)
158. Stewart PW, Lonky E, Reihman J, Pagano J, Gump BB, Darvill T. The relationship between prenatal PCB exposure and intelligence (IQ) in 9-year-old children. Environ Health Perspect 2008; 116(10): 1416-22.
159. Newman J, Aucompaugh AG, Schell LM, Denham M, DeCaprio AP, Gallo MV, et al. PCBs and cognitive functioning of Mohawk adolescents. Neurotoxicol Teratol. 2006;28(4):439-45.
160. Schantz SL, Gasior DM, Polverejan E, McCaffrey RJ, Sweeney AM, Humphrey HE, et al. Impairments of memory and learning in older adults exposed to
161. Haase RF, McCaffrey RJ, Santiago-Rivera AL, Morse GS, Tarbell A. Evidence of an age-related threshold effect of polychlorinated biphenyls (PCBs) on neuropsychological functioning in a Native American population. Environ Res. 2009; 109(1):73-85.
162. Carpenter DO, Arcaro K, Spink DC. Understanding the human health effects of chemical mixtures. Environ Health Perspect 2002;110 Suppl 1:25-42.
163. Carpenter DO, Nevin R. Environmental causes of violence. Physiol Behav. 2010;99(2):260-8.
164. Carpenter DO. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health. 2006;21(1): 1-23.
165. Dewailly E, Ayotte P, Bruneau S, Gingras S, Belles-Isles M, Roy R. Susceptibility to infections and immune status in Inuit infants exposed to organochlorines. Environ Health Perspect 2000; 108(3):205-11. (Pubitemid 30195577)
166. Dallaire F, Dewailly E, Vézina C, Muckle G, Weber JP, Bruneau S, et al. Effect of prenatal exposure to polychlorinated biphenyls on incidence of acute respiratory infections in preschool Inuit children. Environ Health Perspect 2006; 114(8): 1301-5.
167. Weisglas-Kuperus N, Vreugdenhil HJ, Mulder PG. Immunological effects of environmental exposure to polychlorinated biphenyls and dioxins in Dutch school children. Toxicol Lett. 2004; 149(1-3):281-5.
168. Van Den Heuvel RL, Koppen G, Staessen JA, Hond ED, Verheyen G, Nawrot TS, et al. Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents (Belgium). Environ Health Perspect 2002;110(6):595-600.
169. Wang SL, Su PH, Jong SB, Guo YL, Chou WL, Päpke O. In utero exposure to dioxins and polychlorinated biphenyls and its relations to thyroid function and growth hormone in newborns. Environ Health Perspect 2005 Nov; 113(11): 1645-50.
170. Schell LM, Gallo MV, Denham M, Ravenscroft J, DeCaprio AP, Carpenter DO. Relationship of thyroid hormone levels to levels of polychlorinated biphenyls, lead, p,p'- DDE, and other toxicants in Akwesasne Mohawk youth. Environ Health Perspect 2008;116(6):806-13.
171. Lione A. Polychlorinated biphenyls and reproduction. Reprod Toxicol. 1988;2(2):83-9.
172. Faroon OM, Keith S, Jones D, de Rosa C. Effects of polychlorinated biphenyls on development and reproduction. Toxicol Ind Health. 2001;17(3):63-93. (Pubitemid 34712309)
173. Ma R, Sassoon DA. PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract. Environ Health Perspect 2006; 114(6):898-904.
174. DeCastro BR, Korrick SA, Spengler JD, Soto AM. Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ Sci Technol. 2006;40(8):2819-25.
175. Goncharov A, Rej R, Negoita S, Schymura M, Santiago-Rivera A, Morse G, et al. Lower serum testosterone associated with elevated polychlorinated biphenyl concentrations in Native American men. Environ Health Perspect 2009; 117(9): 1454-60.
176. Taylor PR, Stelma JM, Lawrence CE. The relation of polychlorinated biphenyls to birth weight and gestational age in the offspring of occupationally exposed mothers. Am J Epidemiol. 1989; 129(2): 395-406.
177. Rylander L, Strömberg U, Dyremark E, Ostman C, Nilsson-Ehle P, Hagmar L. Polychlorinated biphenyls in blood plasma among Swedish female fish consumers in relation to low birth weight. Am J Epidemiol. 1998;147(5):493-502.
178. Fein GG, Jacobson JL, Jacobson SW, Schwartz PM, Dowler JK. Prenatal exposure to polychlorinated biphenyls: effects on birth size and gestational age. J Pediatr. 1984;105(2):315-20.
179. Baibergenova A, Kudyakov R, Zdeb M, Carpenter DO. Low birth weight and residential proximity to PCB-contaminated waste sites. Environ Health Perspect 2003, 111(10):1352-1357.
180. Halldorsson TI, Thorsdottir I, Meltzer HM, Nielsen F, Olsen SF. Linking exposure to polychlorinated biphenyls with fatty fish consumption and reduced fetal growth among Danish pregnant women: a cause for concern? Am J Epidemiol. 2008;168 (8):958-65.
181. Buck GM, Tee GP, Fitzgerald EF, Vena JE, Weiner JM, Swanson M, et al. Maternal fish consumption and infant birth size and gestation: New York State Angler Cohort Study. Environ Health. 2003;2(1):7. (Pubitemid 38813912)
182. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care. 2006;29(7): 1638-44.
183. Kouznetsova M, Huang X, Ma J, Lessner L, and Carpenter DO. Increased rate of hospitalization for diabetes and residential proximity of hazardous waste sites. Environ Health Perspect 2007;115(1): 75-9.
184. Codru N, Schymura MJ, Negoita S; Akwesasne Task Force on Environment, Rej R, Carpenter DO. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 2007;115(10):1442-7.
185. Goncharov A, Haase RF, Santiago-Rivera A, Morse G; Akwesasne Task Force on the Environment, McCaffrey RJ, et al. High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population. Environ Res. 2008;106(2):226-39.
186. Goncharov A, Bloom MS, Pavuk M, Carpenter DO for the Anniston Environmental Health Research Consortium. Blood pressure and hypertension in relation to levels of serum polychlorinated biphenyls in residents of Anniston, Alabama J Hyperten 2010; 28. Eprint ahead of publication.
187. Roze E, Meijer L, Bakker A, Van Braeckel KNJA, Sauer PJ, Bos AF. Prenatal exposure to organohalogens, including brominated flame retardants, influences motor, cognitive, and behavioral performance at school age. Environ Health Perspect 2009; 117( 12): 1953-8.
188. Slotkin TA, MacKillop EA, Melnick RL, Thayer KA, Seidler FJ. Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. Environ Health Perspect 2008; 116(6):716-22.
189. Blocksom KA, Lazorchak JM, Walters DM, Jicha TM, Angradi TR, Bolgrien DW. Fish tissue contamination in the mid-continental great rivers of the United States. Presented at SWIMS Conference, Chicago, IL, February 09 -11, 2009.
190. Giesy JP, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol. 2001;35(7): 1339-42.
191. Shaw SD, Kannan K. Polybrominated diphenylethers in marine ecosystems of the American continents: foresight from current knowledge. Rev Environ Health 2009; 24(3): 157-229.
192. Institute of Medicine (IOM). Dioxins and dioxinlike compounds in the food supply. The National Academies Press; 2000.
193. United States Environmental Protection Agency. (USEPA). Guidance for assessing chemical contaminant data for use in fish advisories. Vol. 2 Risk assessment and fish consumption limits, Third Edition. TAMS Consultants, Inc., Menzie-Cura & Associates, Inc., for U.S. Environmental Protection Agency Region II and U.S. Army Corps of Engineers Kansas City District; 2000.
194. Hites RA, Foran JA, Carpenter DO, Hamilton MC, Knuth BA, Schwager SJ. Global assessment of organic contaminants in farmed salmon. Science 2004;303(5655):226-9.
195. Mahaffey KR, Clickner RP, Jeffries RA. Methylmercury and omega-3 fatty acids: co-occurrence of dietary sources with emphasis on fish and shellfish. Environ Res. 2008;107(1):20-9.
196. Svensson BG, Nilsson A, Hansson M, Rappe C, Akesson B, Skerfving S. Exposure to dioxins and dibenzofurans through the consumption of fish. N Engl J Med. 1991;324(1):8-12.
197. Hardell S, Tilander H, Welfinger-Smith G, Carpenter DO. Levels of polychlorinated biphenyls (PCBs) and three organochlorine pesticides in fish from the Aleutian Islands of Alaska. Plos One. In press.
198. Cohen JT, Bellinger DC, Connor WE, KrisEtherton PM, Lawrence RS, Savitz DA, et al. A quantitative risk-benefit analysis of changes in population fish consumption. Am J Prev Med. 2005;29(4):325-34.
199. Gochfeld M, Burger J. Good fish/bad fish: a composite benefit-risk by dose curve. Neurotoxicology. 2005;26(4):511-20.
200. Budtz-Jorgensen E, Grandjean P, and Weihe P. Separation of risks and benefits of seafood intake. Environ Health Perspect 2007; 115(3):323-7. (Pubitemid 46554428)
201. Mozaffarian D. Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions. Int J Environ Res Public Health. 2009;6(6): 1894-916.
202. Ginsberg GL, Toal BF. Quantitative approach for incorporating methylmercury risks and omega-3 fatty acid benefits in developing species-specific fish consumption advice. Environ Health Perspect 2009;117(2):267-75.
203. Foran JA, Good DH, Carpenter DO, Hamilton MC, Knuth BA, Schwager SJ. Quantitative analysis of the benefits and risks of consuming farmed and wild salmon. J Nutr. 2005;135(11): 2639-43.
204. World Health Organization (WHO). Diet, nutrition, and the prevention of chronic diseases. Report of a WHO/FAO expert consultation. WHO, Geneva, Switzerland. (Technical Series NO. 916), 2003.
205. Kannan K, Tanabe S, Tatsukawa R. Geographical distribution and accumulation features of organochlorine residues in fish in Tropical Asia and Oceania. Environ Sci Technol 1995;29:2673-83.
206. Marckmann P, Grønbaek M. Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur J Clin Nutr. 1999;53(8):585-90.
207. Fclsom AR, Demissie Z. Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women. Am J Epidemiol. 2004; 160(10):1005-10.
208. Hunter DJ, Kazda I, Chockalingam A, Fodor JG. Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison. Am J Prev Med. 1988;4(1):5-10.
209. Turunen AW, Verkasalo PK, Kiviranta H, Pukkala E, JuIa A, Männistö S, et al. Mortality in a cohort with high fish consumption. Int J Epidemiol 2008;37(5):1008-17.
210. Tomasallo C, Anderson H, Haughwout M, Imm P, Knobeloch L. Mortality among frequent consumers of Great Lakes sport fish. Environ Res. 2010; 110 (1):62-9.
211. Ebbesson SOE, Risica PM, Ebbesson LOE, Kennish JM. Eskimos have CHD despite high consumption of omega-3 fatty acids: The Alaska Siberia Project. Int J Circumpolar Health. 2005 ;64 (4):387-95.
212. Jørgensen C, Enberg K, Dunlop ES, Arlinghaus R, Boukal DS, Brander K, et al. Ecology: managing evolving fish stocks. Science. 2007;318(5854): 1247-8. (Pubitemid 350172878)
213. Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-thecounter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med. 2003; 127(12): 1603-5.
214. Hilbert G, Lillemark L, Balchen S, Hojskov CS. Reduction of organochlorine contaminants from fish oil during refining. Chemosphere. 1998;37(7): 1241-52.
215. Fernandes AR, Rose M, White S, Mortimer DN, Gem M. Dioxins and polychlorinated biphenyls (PCBs) in fish oil dietary supplements: occurrence and human exposure in the UK. Food Addit Contam. 2006;23(9):939-47.